Cite
HARVARD Citation
Moskowitz, A. et al. (n.d.). PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Lancet oncology. 16 (3), pp. 284-292. [Online].